|
Volumn 46, Issue 6, 2014, Pages 527-528
|
PARK2 orchestrates cyclins to avoid cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLIN D1;
CYCLIN DEPENDENT KINASE;
CYCLIN DEPENDENT KINASE 2;
CYCLIN DEPENDENT KINASE 4;
CYCLIN DEPENDENT KINASE 6;
CYCLIN E;
CYCLIN E1;
CYCLINE;
PROTEIN PARK2;
UBIQUITIN PROTEIN LIGASE E3;
UNCLASSIFIED DRUG;
BREAST CANCER;
CARCINOGENESIS;
CELL CYCLE PROGRESSION;
CELL CYCLE REGULATION;
CELL CYCLE S PHASE;
CELL PROLIFERATION;
CELL STRESS;
CHROMOSOMAL INSTABILITY;
COPY NUMBER VARIATION;
GENE MUTATION;
GENOMIC INSTABILITY;
HUMAN;
LOSS OF FUNCTION MUTATION;
ONCOGENE;
OVARY CANCER;
PRIORITY JOURNAL;
PROTEIN METABOLISM;
PROTEIN PROTEIN INTERACTION;
SHORT SURVEY;
ANIMALS;
CELL CYCLE;
CYCLIN D1;
CYCLIN E;
CYCLIN-DEPENDENT KINASE 4;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
ONCOGENE PROTEINS;
UBIQUITIN-PROTEIN LIGASES;
|
EID: 84901642481
PISSN: 10614036
EISSN: 15461718
Source Type: Journal
DOI: 10.1038/ng.2992 Document Type: Short Survey |
Times cited : (19)
|
References (15)
|